In Vitro Degradation of Extracellular Matrix with Mr 52,000 Cathepsin D Secreted by Breast Cancer Cells

Cancer Research

Volumn 48, Issue 13, 1988, Pages 3688-3692

  Briozzo, P ^a   Morisset, M ^a   Capony, F ^a   Rougeot, C ^a   Rochefort, H ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; RADIOISOTOPE;

ANIMAL CELL; BREAST CANCER CELL; CATTLE; CELL CULTURE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; NONHUMAN;

BREAST NEOPLASMS; CATHEPSIN D; COLLAGEN; ENZYME PRECURSORS; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HUMAN; HYDROGEN-ION CONCENTRATION; IN VITRO; PEPSTATINS; PROTEOGLYCANS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0023784140     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lippman, M. Hormones and breast cancer. Banbury Rep., 8:171,1981.
2. Rochefort, H., Capony, F., Garcia, M., Cavailles, V., Freiss, G., Chambon, M., Morisset, M., and Vignon, F. Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis? J. Cell. Biochem., 35:17-29, 1987.
3. Capony, F., Morisset, M., Barrett, A. J., Capony, J. P., Broquet, P., Vignon, F., Chambon, M., Louisot, P., and Rochefort, H. Phosphorylation, glycosylation, and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J. Cell. Biol., 104:253-262,1987.
4. Augereau, P., Garcia, M., Mattei, M. G., Cavailles, V., Depadova, F., Derocq, D., Capony, F., Ferrara, P., and Rochefort, H. Cloning and sequencing of the 52K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome 11. Mol. Endocrinol., 2:186-192,1988.
5. Hasilik, A., Von Figura, K., Conzerlmann, E., Nehrkorn, H., and Sandhoff, K. Activation of cathepsin D precursor in vitro and activity of β-hexosamin-idase, a precursor towards ganglioside gm2. Eur. J. Biochem., 125:317-321, 1982.
6. Reich, E. In: Molecular basis of biological degradative processes. R. D. Berlin, M. Herrman, I. H. Lepow, and J. M. Tanzer (eds.), p. 155. New York: Academic Press, 1978.
7. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284:67-68,1980.
8. Goldfarb, R. H. Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices. In: K. V. Honn, W. E. Powers, and B. F. Sloane (eds.), Mechanisms of Cancer Metastasis. Potential Therapeutic Implications, pp. 341–373. Boston: Martinus Nijhoff Pub. 1986.
9. Butler, W. B., Kirkland, W. L., and Jorgensen, T. L. Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF7). Biochem. Biophys. Res. Commun., 90:1328-1334,1979.
10. Sloane, B. F., Dunn, J. R., and Honn, K. V. Lysosomal cathepsin B: correlation with metastatic potential. Science (Wash. DC), 212:1151-1153, 1981.
11. Recklies, A. D., Tiltman, K. J., Stoker, A. M., and Poole, A. R. Secretion of proteinase from malignant and nonmalignant human breast tissue. Cancer Res., 40:550-556,1980.
12. Szego, C. M. The lysosome as a mediator of hormone action. Recent Prog. Honn. Res., 30:171-233,1974.
13. Garcia, M., Salazar, G., Pages, A., Richer, G., Domergue, J., Pages, A. M., Cavalie, G., Martin, P. M., Lamarque, J. L., Pau, B., and Rochefort, H. Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry. Cancer Res., 46:3734-3738,1986.
14. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A Human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51:1409-1413,1973.
15. Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., and Brenner, H. J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer, 15:659-670,1979.
16. Cailleau, R., Young, R., Olive, M., and Reeves, W. J. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst, 53:661-674,1974.
17. Ueda, M., Hagino, Y., Ono, M., and Kuwano, M. Human mammary cancer cell mutants with altered hormone receptor activity. J. Biochem., 100:341-348, 1986.
18. Westley, B., and Rochefort, H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20:352-362,1980.
19. Gey, G. O., Coffman, W. D., and Kubicek, M. T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res., 12:264-265,1952.
20. Nishida M., Kasahara K., Kaneko M. and Iwasaki H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynaecol Jpn., 37:1103-1111.1985. (In Japanese.)
21. Fabricant, R. N., DeLarco, J. E., and Todaro, G. Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl. Acad. Sci. USA, 74:565-569,1977.
22. Stampfer, M., Hallowes, R. C., and Hackett, A. J. Growth of normal human mammary cells in culture. In Vitro (Rockville), 16:415-425,1980.
23. Chambon, M., Cavalie-Barthez, G., Veith, F., Vignon, F., Hallowes, R., and Rochefort, H. Effect of estradiol on nonmalignant human mammary cells in primary culture. Cancer Res., 44:5733-5743,1984.
24. Gospodarowicz, D., Delgado, D., and Vlodavsky, I. Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc. Natl. Acad. Sci. USA, 77:4094-4098,1980.
25. Gospodarowicz, D. Preparation of extracellular matrices produced by cultured bovine corneal endothelial cells and PF-HR-9 endodermal cells: their use in cell culture. In: Methods for Preparation of Media, Supplements, and Substrata for Serum-free Animal Cell Culture, pp. 275–293. New York: Alan R. Liss, Inc., 1984.
26. Jones, P. A., Scott-Burdent, T., and Gevers, W. Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc. Natl. Acad. Sci. USA, 76:353-357,1979.
27. Capony, F., Garcia, M., Capdevielle, J., Rougeot, C., Ferrara, P., and Rochefort, H. Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human breast cancer cells. Eur. J. Biochem., 161:505-512,1986.
28. Vignon, F., Derocq, D., Chambon, M., and Rochefort, H. Endocrinologie. Les proteines oestrogeno-induites secretees par les cellules mammaires can-cereuses humaines MCF7 stimulent leur proliferation. C. R. Acad. Sci. Paris, 296:151-156,1983.
29. Berthois, Y., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA, 83:2496-2500.1986.
30. Garcia, M„ Capony, F., Derocq, D., Simon, D., Pau, B., and Rochefort, H. Monoclonal antibodies to the estrogen-regulated M, 52,000 glycoprotein: characterization and immunodetection in MCF7 cells. Cancer Res., 45:709-716,1985.
31. Maudelonde, T., Khalaf, S., Garcia, M., Freiss, G., Duporte, J., Benatia, M., Rogier, H., Paolucci, F., Simony, J., Pujol, H., Pau, B., and Rochefort, H. Immunoenzymatic assay of Mr52,000 cathepsin D in 182 breast cancer cytosols. Low correlation with other prognostic parameters. Cancer Res., 48: 462-466,1988.
32. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-250,1976.
33. Samarel, A. M., Worobec, S. W., Ferguson, A. G., Decker, R. S., and Lesch, M. Limited proteolysis of rabbit cardiac pro-cathepsin D in a cell-free system. Am. J. Physiol., 250: C589-596,1986.
34. Barrett, A. J. Cathepsin D: purification of isoenzymes from human and chicken liver. Biochem. J., 117:601-607,1970.
35. Yee, C., and Shiu, R. P. C. Degradation of endothelial basement membrane by human breast cancer cell lines. Cancer Res., 46:1835-1839,1986.
36. Burleigh, M. C. Degradation of collagen by non-specific proteinases. In: A. J. Barrett (ed.), Proteinases in Mammalian Cells and Tissues, pp. 285–309. Amsterdam: Elsevier/North-Holland Biomedical Press, 1977.
37. Mitrovic, D. R., Gruson, M., and Rickewaert A. Local hyparthermia and cartilage breakdown: histochemical and metabolic studies on rabbit articular cartilage in vitro. J. Rheumatol., 8:193-203,1981.
38. Dingle, J. T., Barrett, A. J., and Weston, P. D. Cathepsin D, characteristics of immuno-inhibition and the confirmation of a role in cartilage breakdown. Biochem. J., 123:1-13,1971.
39. Barrett, A. J. Cathepsin D and other carboxyl proteinases. In: A. J. Barrett (ed.), Proteinases in Mammalian Cells and Tissues, pp. 209–248. Amsterdam: Elsevier/North-Holland Biomedical Press, 1977.
40. Carrel, A., and Baker, L. E. The chemical nature of substances required for cell multiplication. J. Exp. Med., 44:503-521,1926.
41. Baron, R., Neff, L., Louvard, D., and Courtoy, P. J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100 Kd lysosomal membrane protein at the osteoclast ruffled border. J. Cell. Biol., 101:2210-2222,1985.
42. Van Beek, W. P., Smets, L. A., and Emmelot, P. Increased sialic acid density in surface glycoprotein of transformed and malignant cells. A general phenomenon? Cancer Res., 33:2913-2922,1973.
43. Spechler, S. J., Esposito, A. L., Koff, R. S., et al. Lactic acidosis in oat cell carcinoma with extensive hepatic metastases. Arch. Intern. Med., 138:1663-1664,1978.
44. Gal, S., and Gottesman, M. M. The mqjor excreted protein of transformed fibroblasts is an activatable acid-protease. J. Biol. Chem., 261: 1760–1765, 1986.
45. Theillet, C., Lidereau, R., Escot, C., Hutzell, P., Brunet, M., Gest, J., Schlom, J., and Callahan, R. Frequent loss of a H-ras-l allele correlates with aggressive human primary breast carcinomas. Cancer Res., 46:4776-4781,1986.